HIV prevalence — all countries

HIV prevalence — Middle East & North Africa

HIV prevalence in Middle East & North Africa in 2024 — 0.14%. Since 1990, the indicator has risen by 0.03 pp.

2024 0.14% −0 pp vs 2023
World rank
Period maximum 0.14%2018
Period minimum 0.1%1990

Trend over time

1990–2024 · % of population aged 15–49

HIV prevalence — Middle East & North Africa, 1990–20240.10.110.120.130.1419901994199820022006201020142018202220241990: 0.1%1991: 0.1%1992: 0.1%1993: 0.1%1994: 0.1%1995: 0.1%1996: 0.1%1997: 0.11%1998: 0.11%1999: 0.11%2000: 0.11%2001: 0.11%2002: 0.11%2003: 0.11%2004: 0.11%2005: 0.11%2006: 0.11%2007: 0.11%2008: 0.1%2009: 0.1%2010: 0.1%2011: 0.1%2012: 0.1%2013: 0.1%2014: 0.1%2015: 0.1%2016: 0.1%2017: 0.1%2018: 0.14%2019: 0.14%2020: 0.14%2021: 0.14%2022: 0.14%2023: 0.14%2024: 0.14%
Change over the period: +0.03 pp Annual average: 0 pp

Comparison, 2024

How the value compares with the world and the groups this territory belongs to: Middle East & North Africa

Middle East & North Africa 0.14%
World 0.7%
HIV prevalence — Middle East & North Africa, by year Middle East & North Africa All countries CSV XLSX
Year % Change, pp
2024 0.14 −0 pp
2023 0.14 −0 pp
2022 0.14 −0 pp
2021 0.14 +0 pp
2020 0.14 −0 pp
2019 0.14 −0 pp
2018 0.14 +0.03 pp
2017 0.1 −0 pp
2016 0.1 −0 pp
2015 0.1 −0 pp
2014 0.1 −0 pp
2013 0.1 −0 pp
2012 0.1 −0 pp
2011 0.1 −0 pp
2010 0.1 −0 pp
2009 0.1 −0 pp
2008 0.1 −0 pp
2007 0.11 −0 pp
2006 0.11 −0 pp
2005 0.11 −0 pp
2004 0.11 −0 pp
2003 0.11 −0 pp
2002 0.11 +0 pp
2001 0.11 +0 pp
2000 0.11 +0 pp
1999 0.11 +0 pp
1998 0.11 +0 pp
1997 0.11 +0 pp
1996 0.1 +0 pp
1995 0.1 +0 pp
1994 0.1 +0 pp
1993 0.1 +0 pp
1992 0.1 +0 pp
1991 0.1 +0 pp
1990 0.1

About the indicator

The share of the population aged 15–49 living with HIV, as estimated by UNAIDS. The age range is chosen as the period of greatest sexual activity. In several countries of Southern Africa the indicator exceeds 15%, which makes HIV a key factor limiting life expectancy in the region.

Source: Global Health Observatory (WHO), license CC BY-NC-SA 3.0 IGO.